Building Korro Bio: A CEO’s Perspective on Innovation and Risk Management
LifeSciVC
JUNE 12, 2025
Josh’s work at the Marine Biological Laboratory unlocked the potential of utilizing an endogenous protein to make a single alphabet change on RNA (RNA editing), a process that was precise, reversible and had druglike characteristics. We intended to learn from nature (genetics) and use pharmaceuticals properties to drive patient benefit.
Let's personalize your content